發送短信 : Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

           __   __    _____     _____             
  ____     \ \\/ //  / ____||  |  ___||   ____    
 |    \\    \ ` //  / //---`'  | ||__    |    \\  
 | [] ||     | ||   \ \\___    | ||__    | [] ||  
 |  __//     |_||    \_____||  |_____||  |  __//  
 |_|`-`      `-`'     `----`   `-----`   |_|`-`   
 `-`                                     `-`